Inventor · disambiguated record
Oyewale O. Abidoye
Also filed as: ABIDOYE OYEWALE · ABIDOYE OYEWALE O
3 granted patents·10 pending applications·0 citations·filing 2018–2023
39Inventor score
Top patents by PatentIndex Score
13 records- 0167US2024076402A1Humanized anti-liv1 antibodies for the treatment of breast cancerSEAGEN INC·Filed 2023·Application pending·0 cites
- 0258US2025249115A1Combination therapy for treating tumor antigen expressing cancersGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 0356US12246025B2Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2019·Granted Mar 11, 2025·0 cites·25 claims
- 0456US2020283540A1Humanized anti-liv1 antibodies for the treatment of breast cancerSEATTLE GENETICS INC·Filed 2018·Application pending·0 cites
- 0554US2021107980A1Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2019·Application pending·0 cites
- 0649US2025064956A1Methods for treating muscle invasive urothelial cancer or muscle invasive bladder cancer with antibody drug conjugates (adc) that bind to 191p4d12 proteinsAGENSYS INC·Filed 2023·Application pending·0 cites
- 0748US12453781B2Methods of treating cancer with a combination of an anti-VEGF antibody and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2019·Granted Oct 28, 2025·0 cites·36 claims
- 0848US2021308208A1Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancerGENMAB AS·Filed 2019·Application pending·0 cites
- 0946US2022387485A1Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2020·Application pending·0 cites
- 1045US2021030888A1Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancerGENMAB AS·Filed 2019·Application pending·0 cites
- 1144US2023027495A1Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2020·Application pending·0 cites
- 1240US2023001005A1Treatment of cancers with antibody drug conjugates (adc) that bind to 191p4d12 proteinsAGENSYS INC·Filed 2020·Application pending·0 cites
- 1338US12324841B2Methods of treating cancer with a combination of an anti-PD-1 antibody and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2019·Granted Jun 10, 2025·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Oyewale O. Abidoye files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →